Stage II colorectal cancer trang 1 tải miễn phí từ TAILIEUCHUNG

"Stage II colorectal cancer" trang 1 - tải miễn phí từ Tailieuchung

Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

13 18 1

Risk factors for recurrence in elderly patients with stage II colorectal cancer: A multicenter retrospective study

Risk factors for recurrence in elderly patients with stage II colorectal cancer: A multicenter retrospective study

7 7 1

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer

15 54 0

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer

11 35 1

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

13 62 1

A network-based predictive geneexpression signature for adjuvant chemotherapy benefit in stage II colorectal cancer

A network-based predictive geneexpression signature for adjuvant chemotherapy benefit in stage II colorectal cancer

13 27 1

Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients

Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients

14 19 1

The ASAMET trial: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

The ASAMET trial: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

9 43 1

Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

8 39 1

CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy

CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy

10 44 1

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer

24 41 1

Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer

Higher body mass index was associated with better prognosis in diabetic patients with stage II colorectal cancer

9 15 1

Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: A nationwide multicenter retrospective study

Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: A nationwide multicenter retrospective study

10 14 1

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

9 32 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.